Public Health Archives - Life Sciences Times

Antares Therapeutics Launches with $177 Million to Advance First-in-Class Precision Medicines

June 10, 2025

European Commission Approves Alnylam’s AMVUTTRA for ATTR Amyloidosis with Cardiomyopathy

June 9, 2025

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

June 7, 2025

THIS WEEK'S STORIES

Commonwealth Radiology Associates to Provide Imaging Services for Heywood Healthcare

June 10, 2025

Vertex Highlights Potential of ALYFTREK in Cystic Fibrosis at European Conference

June 7, 2025

SoundHealth’s SONU Band Receives FDA Approval for Pediatric Use in Treating Nasal Congestion and Allergies

June 11, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Public Health

Genetic Marker Linked to Immunotherapy Resistance in Deadly Skin Cancer, NYU Study Finds

Ontario Brain Injury Association Warns of Hidden Dangers in Surviving Opioid Overdoses

ZOLL and Simon’s Heart Donate AEDs to 32 Youth Organizations Nationwide in Honor of CPR and AED Awareness Week

Affinia Therapeutics and DCM Foundation Launch Awareness Campaign for Genetic Heart Disease BAG3 DCM

Animal Diseases Spreading to New Species, Nearly Half Pose Human Health Risk: Global Report

Most Read

FDA Expands Approval of MAVYRET® to Include Treatment for Acute Hepatitis C, Offering First-Ever Eight-Week Cure Option

FDA Approves Nuvation Bio’s IBTROZI™ for Advanced ROS1-Positive Lung Cancer

Vivex Biologics Names Dr. Jon E. Block as Chief Clinical Officer to Lead Spine Therapy Trials

DT Research and Homeland Language Services Launch Mobile 5G Telehealth Translation Stations to Bridge Language Gaps in Healthcare

EDITOR PICKS